Table 3.
30 min | 90 min | |||||
---|---|---|---|---|---|---|
Symptom | Before | After | + 20 min | Before | After | + 20 min |
Nasal irritation | 0.25 (0–1) | 2 (0.25–2)** | 0 (0–1) | 0.25 (0–1) | 2 (0.875–3)** | 0.5 (0–1) |
Nasal mucus | 1 (0.375–2.25) | 4 (3–5)*** | 1 (0.5–2) | 1 (0.75–2) | 5 (4–6.25)*** | 0.75 (0.375–2) |
Cold face | 0 (0–0) | 3 (2–4.5)*** | 0 (0–0.625)* | 0 (0–0) | 3.5 (3–6)*** | 0.25 (0–1)* |
Cold extremities | 0 (0–0.6) | 3 (0–4.5)** | 0.5 (0–1) | 0 (0–0.875) | 3.5 (1.75–6.5)**† | 1.25 (0–3) |
Physical discomfort | 0 (0–0.5) | 2 (0–3)** | 0 (0–0.5) | 0 (0–0.5) | 2.5 (0.5–4)** | 0.5 (0–2)† |
Shortness of breath | 0 (0–0.5) | 2 (1–2)** | 0 (0–1) | 0 (0.25–0.5) | 2 (1–3)*** | 0.25 (0–0.5) |
Warm in body | 1.5 (0–3) | 3 (0.75–4) | 1 (0.5–3) | 2 (0.5–3) | 4 (2–5)**† | 3 (1.25–3.5)† |
Irritation in the chest | 0 (0–0.5) | 0 (0–2) | 0.25 (0–1) | 0 (0–1) | 1.25 (0–2)** | 0.5 (0–2) |
Irritation in the mouth and throat | 1 (0.375–2.25) | 4 (3–5) | 1 (0–2) | 1 (0.75–2) | 5 (4–6.25)** | 1 (0–2.25) |
Data are presented as median (IQR). Significant difference within trial, compared to baseline (*, p < 0.05, **, p < 0.01; ***, p < 0.001); †Significant difference between trials (p < 0.05)